Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
autologous hematopoietic stem cells (1 trial)
carmustine (bicnu) (1 trial)
cyclophosphamide (cytoxan) (1 trial)
cytarabine (cytosar-u) (1 trial)
etoposide (vepesid) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
melphalan (alkeran) (1 trial)
sargramostim (leukine) (1 trial)
urea (1 trial)
Lymphoma (Phase 3)
Lymphoma, Mantle-Cell (Phase 3)
Trials (1 total)
Trial APIs (9 total)